W. Hoelle

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

K. Dietz, M. Schrappe, G. Henze, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of allogeneic stem cell transplantation in children with non-malignant diseases.

T. Klingebiel, R. Handgretinger, P. Bader, 2006, Haematologica.

Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia

T. Klingebiel, B. Gruhn, P. Bader, 2004, Bone Marrow Transplantation.

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

D. Reinhardt, C. Niemeyer, T. Klingebiel, 2004, Bone Marrow Transplantation.

Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.

C. Belka, T. Klingebiel, R. Handgretinger, 2006, Blood cells, molecules & diseases.

Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation

M. Ebinger, R. Handgretinger, W. Bethge, 2007, Bone Marrow Transplantation.